Cancer Policy Cancer patients with Medicare Advantage have access to fewer providers than Medicare patients, cross-sectional study finds July 10, 2026Vol.52 No.27By Sara Willa Ernst
Cancer Policy CMS proposes end-of-life counseling provision, echoing ACA “death panels” controversy July 10, 2026Vol.52 No.27By Claire Marie Porter
Cancer Policy FDA proposes rule to hold foreign tobacco companies to U.S. standards July 10, 2026Vol.52 No.27By Claire Marie Porter
In Brief ARPA-H awards up to $160M to advance personalized curative medicines for rare genetic diseases July 10, 2026Vol.52 No.27
Clinical Roundup Zoldonrasib + daraxonrasib show 81% ORR in patients with RAS G12D metastatic pancreatic cancer, phase I/II study finds July 10, 2026Vol.52 No.27
Clinical Roundup HIF-2α inhibitor casdatifan yields 35% response rate in kidney cancer, phase I study finds July 10, 2026Vol.52 No.27
Clinical Roundup Young women diagnosed with breast cancer within three years of childbirth may face more aggressive disease, UCLA study finds July 10, 2026Vol.52 No.27
Clinical Roundup Portable ultrasound system could make reliable breast imaging more accessible, MIT study finds July 10, 2026Vol.52 No.27
